CIK 0001642380
- Non-accelerated filer
- Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 271041563
- Phone
- +1 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-09-11 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +0 | 11,098,267 | ||
| 2019-07-17 | Redmond Cavan M. Director | Grant or award · Option to Purchase Common Stock | +50,000 | 50,000 | ||
| 2019-07-17 | MOHANTY ADITYA P. Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2019-07-17 | KINGSLEY ALFRED D Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2019-07-17 | Last Andrew J. Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2019-07-17 | Arno Andrew Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2019-07-05 | BIOTIME INC 10% owner | Sale | −2,250,000 | $2.00 | $4.5M | 12,424,244 |
| 2019-07-02 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +1,000,000 | $2.00 | $2.0M | 9,098,267 |
| 2019-07-02 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +0 | $2.00 | $0 | 9,098,267 |
| 2019-07-01 | ANDREWS RONALD ASBURY Chief Executive Officer | Grant or award · Option to Purchase Common Stock | +950,000 | 950,000 | ||
| 2019-03-14 | ANNETT WILLIAM President and CEO | Grant or award · Option to Purchase Common Stock | +390,000 | 390,000 | ||
| 2019-03-14 | Levine Mitchell S Chief Financial Officer | Grant or award · Option to Purchase Common Stock | +245,000 | 245,000 | ||
| 2019-03-14 | Levine Mitchell S Chief Financial Officer | Grant or award · Restricted Stock Units | +20,000 | 20,000 | ||
| 2019-03-14 | HESTERBERG LYNDAL K. Chief Scientific Officer | Grant or award · Option to Purchase Common Stock | +350,000 | 350,000 | ||
| 2019-03-14 | Parker Albert P Chief Operating Officer | Grant or award · Option to Purchase Common Stock | +200,000 | 200,000 | ||
| 2019-02-15 | MOHANTY ADITYA P. Director | Grant or award · Option to Purchase Common Stock | +33,750 | 33,750 | ||
| 2019-02-08 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +533,333 | $3.75 | $2.0M | 8,098,267 |
| 2019-02-08 | BROADWOOD PARTNERS, L.P. 10% owner | Purchase | +0 | $3.75 | $0 | 8,098,267 |
| 2018-08-30 | KINGSLEY ALFRED D Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 | ||
| 2018-08-30 | Last Andrew J. Director | Grant or award · Option to Purchase Common Stock | +45,000 | 45,000 |
Page 18 of 20 · 383 trades